Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brain development and metabolic effects of puberty suppression in transgender adolescents
NL-OMON26605Not yet recruiting
- Sponsor
- Vrije University Medical Center
- Start
- Jan 2007
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Open-label trial of triptorelin in gender dysphoria (GD) (3 arms), sponsored by Vrije University Medical Center. Primary endpoints: Cognition, Functional MRI and 1 more. Planned start Jan 2007; status: not yet recruiting.
02
Drugs
triptorelin
03
Conditions
gender dysphoria (GD)
Beyond the preview
Go deeper on NL-OMON26605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26605.